The largest database of trusted experimental protocols

C18 reverse phase hplc column

Manufactured by Agilent Technologies
Sourced in United States

The C18 reverse phase HPLC column is a commonly used analytical tool in High-Performance Liquid Chromatography (HPLC) applications. It is designed to separate and analyze a wide range of organic compounds based on their hydrophobic interactions with the stationary phase.

Automatically generated - may contain errors

7 protocols using c18 reverse phase hplc column

1

Bortezomib Quantification in Spinal Cord

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flash frozen spinal cord tissue samples were mixed with PBS (pH 7.2, 1:1 ratio) and homogenized with a pestle-type homogenizer. The homogenate was treated with 2 volumes of acetonitrile to precipitate the proteins, and the supernatant was analyzed by LCMS/MS. Samples were created for calibration and quality control with a working dilution of bortezomib in warfarin at 50 times the final concentration, and this was serially diluted to make the standard samples. These samples were diluted 31-fold into blank tissue extract and processed as above.
The signal was optimized for bortezomib by electrospray negative ionization (ESI) mode. A MS2 targeted SIM scan was used to optimize the precursor ion, and a product ion analysis was used to identify the best fragment for analysis and to optimize the collision energy.
Samples were analyzed with an ABI3000 mass spectrometer coupled with a Shimadzu HPLC and a Sil-HTc chilled autosampler, all controlled by Analyst software (ABI). After separation on a C18 reverse phase HPLC column (Agilent, Waters, or equivalent) mobile phase A was 0.1% formic acid in water and mobile phase B was 0.1% formic acid in acetonitrile.
+ Open protocol
+ Expand
2

Extraction and Purification of DSF Signaling Molecules

Check if the same lab product or an alternative is used in the 5 most similar protocols
The protocol for extraction and purification of DSF family components was described previously48 (link). In brief, Xcc strains were cultured in liquid medium for 24–48 hours and 50 mL of bacterial supernatant was collected by centrifugation at 3,800 × g for 30 minutes at 4 °C. The pH of the supernatants was adjusted to 4.0 by adding hydrochloric acid prior to two extractions with an equal volume of ethyl acetate. The ethyl acetate fractions were collected and the solvent was removed by rotary evaporation to dryness at 40 °C. The residue was dissolved in 1 mL of methanol. The crude extract was subjected to a 0.45 μm Minisart filter unit and the collected filtrate was concentrated to 0.5 mL. Three microliters of the extract was injected into a C18 reverse-phase HPLC column (4.6 × 150 mm, Agilent Technologies), eluted with water in methanol (23:77, v/v, respectively; 0.1% formic acid) at a flow rate of 1 mL/minute in an Agilent Technologies 1260 Infinity system with a DAD G1315D VL detector.
+ Open protocol
+ Expand
3

Serum L-Arginine Depletion in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 5

Serum Depletion of L-Arg in the Mouse Model

Balb/c mice were treated by single IP injection with 500 μg of pharmacologically prepared, pegylated Co-hArgI or an equal volume of PBS. Mice were sacrificed by cardiac veni-puncture for blood collection at the time points of 0, 48, 72, and 96 hrs. Blood samples were immediately mixed 50:50 (v/v) with a 400 mM sodium citrate buffer pH 4, allowed to clot for 30 minutes and centrifuged for serum separation. The resulting serum was then filtered on a 10,000 MWCO device (Amicon) for the removal of large proteins and precipitates and the flow-through was collected for analysis. L-arginine standards, control mouse serum and experimental samples were derivatized with OPA (Agilent) and separated on a C18 reverse phase HPLC column (Agilent) (5 μm, 4.6×150 mm) essentially as described by Agilent Technologies (Publication Number: 5980-3088) except for modification of the separation protocol slightly by reducing the flow rate by ½ and doubling the acquisition time to get better peak separation. An L-arginine standard curve was constructed by plotting L-Arg peak area versus concentration in order to quantify serum L-Arg levels. A single dose of pharmacologically prepared Co-hArgI was sufficient to keep L-Arg at or below detection limits for over 3 days (FIG. 1).

+ Open protocol
+ Expand
4

Plasma Pharmacokinetics of Test Agent

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD-1 female mice were injected intravenously with a single dose of 20 mg per kg in water and showed no adverse effects. Plasma samples were taken from 3 mice per time point (5, 15, 30 min; 1, 2, 4, 8 and 24 h post-dose). An aliquot of plasma sample or calibration sample was mixed with three volumes of methanol containing internal standard, incubated on ice for 5 min, and centrifuged. The protein-free supernatant was analysed by LC/MS/MS using an Agilent 6410 mass spectrometer coupled with an Agilent 1200 HPLC and a CTC PAL chilled autosampler, all controlled by MassHunter software (Agilent). After separation on a C18 reverse phase HPLC column (Agilent) using an acetonitrile-water gradient system, peaks were analysed by mass spectrometry using ESI ionization in MRM mode. The product m/z analysed was 134.1D, which provided a low limit of quantification of 1 ng ml−1. The mean plasma concentration and the standard deviation from all 3 animals within each time point were calculated. PK parameters of test agent were calculated with a non-compartmental analysis model basedon WinNonlin. The mean plasma concentrations fromall3 mice at each time point were used in the calculation.
+ Open protocol
+ Expand
5

ADME In Vitro Analytical Workflow

Check if the same lab product or an alternative is used in the 5 most similar protocols
ADME in vitro studies were performed by APREDICA (Watertown, MA). Samples were analyzed by LC/MS/MS using an Agilent 6410 mass spectrometer coupled with an Agilent 1200 HPLC and a CTC PAL chilled autosampler, all controlled by MassHunter software (Agilent). After separation on a C18 reverse phase HPLC column (Agilent, Waters, or equivalent) using an acetonitrile-water gradient system, peaks were analyzed by mass spectrometry (MS) using ESI ionization in MRM mode.
+ Open protocol
+ Expand
6

Multiresidue Pesticide and Antibiotic Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HPLC-MS/MS system (Agilent technologies, USA) consisted of a 1200 Series liquid chromatographer coupled to a triple quadrupole mass spectrometer (6410 Triple Quad) equipped with an electrospray ionization interface (ESI). All target compounds were separated using a HPLC reverse-phase C18 column (50 mm × 2.1 mm × 3.5 μm, Agilent technologies, USA). The gradient mobile phase consisted of methanol (phase A) and 0.1% formic acid (phase B). The gradient elution program for the 47 pesticides and 10 antibiotics was shown in ESI (Tables S1 and S2). The injection volume was 5 μL and the column temperature was maintained at 30 °C. The total chromatographic run times for the 47 pesticides and 10 antibiotics were 25 min and 13.5 min, respectively. The HPLC–MS/MS was performed in multiple-reaction monitoring (MRM) mode and positive ESI mode. The desolvation gas (N2) temperature was maintained at 350 °C with the gas flow being maintained at 8.0 L min−1, and the nebulizer pressure being maintained at 35 psi. The optimized parameters of the 47 pesticides and 10 antibiotics are provided in Tables S3 and S4.
+ Open protocol
+ Expand
7

HPLC-MS/MS Analysis of Pesticides

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HPLC–MS/MS analysis was achieved using an Agilent 1200 HPLC series (Agilent Technologies, Santa Clara, CA, USA) and an Agilent 6410B triple-quadrupole mass spectrometer equipped with an electrospray ionization interface (ESI±). A HPLC reverse-phase C18 column (50 mm × 2.1 mm × 3.5 μm, Agilent, Santa Clara, CA, USA) was employed for the separation of dichlorprop-P, bentazone, 6-hydroxy-bentazone and 8-hydroxy-bentazone at 30 °C. The mobile phase was acetonitrile and 0.1% formic acid water (v/v = 90/10) at a flow rate of 0.25 mL/min, and the injection volume was 5 μL. The total run time was 2.5 min. The HPLC–MS/MS was performed in negative multiple-reaction monitoring (MRM) mode. The desolvation gas (N2) temperature was set at 350 °C with the gas flow at 8.0 L/min, and the nebulizer pressure at 35 psi. The parameters were optimized individually for each target compound (Table 2).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!